This morning, Prudential issued notes on two of my favorite companies: Boeing Co. (NYSE: BA) and Caterpillar Inc. (NYSE: CAT).
Prudential upped Boeing's target price from $99 to $103 but maintained the Overweight rating. The analyst, Byron Callan, tweaked his model, specifically adding 737 deliveries 2-5 years out. Mostly, however, he sees broader macro factors as a positive.
Prudential notes that other analysts recommending the stock have higher earnings estimates.
Caterpillar, which has been one of my favorite companies and stock for a while now, last week reported better-than-expected results for the first quarter. Booming overseas markets were the main drivers. Indeed, while the North American slumping housing market continues to represent a challenge, the overseas outlook is positive.
Prudential expects the N.American market to start improving in the second half of 2007, as the worst of the housing market slump is likely over. 2008 will be much better for CAT, and investors should focus on that, analyst Igor Maryasis said. He expects CAT's earnings to reaccelerate.
Prudential maintains its Overweight rating, but lifting the 6-12 month price target to $80 from $73, saying CAT's
current 11X 2008 EPS multiple remains attractive.
As for Pfizer Inc. (NYSE: PFE), Prudential downgraded PFE to Neutral Weight from Overweight. Analyst Tim Anderson says that indeed PFE may be at the bottom, but he can't see clearly what would be the catalysts that would lift the stock despite organizational plans announced.
As revenue stream is eroded by generic competition, the analyst says Pfizer has two options: The first is to split up the company, which probably would not happen, the second is another acquisition of a company with phase III pipeline products.
Last updated: February 13, 2012: 02:42 AM
Hot Stocks
DailyFinance Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
Benzinga Headlines
- Michigan Consumer Sentiment Index Drops
- Don't Bank on Barclays
- GSV Capital Punished for Expanding Facebook Investment
- Chesapeake Gently Lets Go of Gas
- How to Profit off Addicts
TheFlyOnTheWall.com Headlines
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Walmart's New Health Food Push: Is It Too Hard to Swallow?
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger

